{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:31:34Z","timestamp":1779917494740,"version":"3.53.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["No. 2022CFB142"],"award-info":[{"award-number":["No. 2022CFB142"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 31500282"],"award-info":[{"award-number":["No. 31500282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017958","name":"Health Commission of Hubei Province","doi-asserted-by":"crossref","award":["No. WJ2021M132"],"award-info":[{"award-number":["No. WJ2021M132"]}],"id":[{"id":"10.13039\/100017958","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Acute lymphoblastic leukemia (ALL) is the predominant malignancy in pediatric patients. As a crucial constituent of ALL chemotherapy,\n                      <jats:sc>l<\/jats:sc>\n                      -asparaginase is recognized as an integral element of treatment with a threshold concentration of 0.1 IU\/mL used in treatment protocols. This study presents a novel liquid chromatography\u2013tandem mass spectrometry method for evaluating plasma\n                      <jats:sc>l<\/jats:sc>\n                      -asparaginase activity in pediatric patients with ALL undergoing pegaspargase therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Initially, an enzyme incubation was conducted using 20 \u03bcL of plasma and 100 \u03bcL of\n                      <jats:sc>l<\/jats:sc>\n                      -asparagine (0.1 mol\/L) at 37\u00b0C for 15 minutes. The reaction was stopped by adding sulfosalicylic acid and methanol. After the addition of isotope internal standard\n                      <jats:sc>l<\/jats:sc>\n                      -aspartic\n                      <jats:sup>13<\/jats:sup>\n                      C\n                      <jats:sub>4<\/jats:sub>\n                      acid, subsequent centrifugation, and dilution, the plasma samples underwent analysis by liquid chromatography\u2013tandem mass spectrometry on a hydrophilic interaction liquid chromatography analytical column. A flow rate of 0.3 mL\/min was used during isocratic elution using a mobile phase consisting of methanol\u2013water (95:5, vol\/vol) with 0.2% formic acid within a 5-minute run.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The calibration curves exhibited excellent linearity ranging from 0.1 to 15 IU\/mL, with determination coefficients (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      ) exceeding 0.99. The precision and accuracy ranged from 1% to 7% and from 93% to 110%, respectively. The relative recovery fell within the range of 98%\u2013100%, and the internal standard\u2013normalized matrix effect ranged from 95% to 101%. The stability was satisfactory across various conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      This method was fully validated and successfully applied to quantify\n                      <jats:sc>l<\/jats:sc>\n                      -asparaginase activity in plasma samples of 15 children with ALL, enabling the monitoring of\n                      <jats:sc>l<\/jats:sc>\n                      -asparaginase activity with mass spectrometry.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001345","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:02:43Z","timestamp":1747998163000},"page":"755-763","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A Novel Liquid Chromatography\u2013Tandem Mass Spectrometry Method for Monitoring Plasma l-Asparaginase Activity in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Pegaspargase Treatment"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5412-5293","authenticated-orcid":false,"given":"Hengyi","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjie","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiguo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuepeng","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"R1-20251107","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R2-20251107","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12032-023-02014-9","article-title":"L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review","volume":"40","author":"Tosta P\u00e9rez","year":"2023","journal-title":"Med Oncol"},{"key":"R3-20251107","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1517\/17460441.2014.956720","article-title":"Novel methods and approaches to acute lymphoblastic leukemia drug discovery","volume":"9","author":"Wei","year":"2014","journal-title":"Expert Opin Drug Discov"},{"key":"R4-20251107","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.3390\/cells10123349","article-title":"Genetic and epigenetic targeting therapy for pediatric acute lymphoblastic leukemia","volume":"10","author":"Xu","year":"2021","journal-title":"Cells"},{"key":"R5-20251107","doi-asserted-by":"crossref","first-page":"102915","DOI":"10.1016\/j.cis.2023.102915","article-title":"L-Asparaginase delivery systems targeted to minimize its side-effects","volume":"316","author":"Talluri","year":"2023","journal-title":"Adv Colloid Interf Sci"},{"key":"R6-20251107","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3324\/haematol.2015.137380","article-title":"Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation","volume":"101","author":"van der Sluis","year":"2016","journal-title":"Haematologica"},{"key":"R7-20251107","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/1078155219838316","article-title":"Optimizing pegylated asparaginase use: an institutional guideline for dosing, monitoring, and management","volume":"26","author":"Bade","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"R8-20251107","doi-asserted-by":"crossref","first-page":"902117","DOI":"10.3389\/fped.2022.902117","article-title":"Current use of asparaginase in acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"10","author":"Maese","year":"2022","journal-title":"Front Pediatr"},{"key":"R9-20251107","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1182\/blood-2013-10-534347","article-title":"A prospective study on drug monitoring of pegasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia","volume":"123","author":"Tong","year":"2014","journal-title":"Blood"},{"issue":"suppl l","key":"R10-20251107","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.clml.2014.06.017","article-title":"Asparaginase in acute lymphoblastic leukemia","volume":"14","author":"Kawedia","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R11-20251107","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-200544040-00003","article-title":"Pharmacokinetic\/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future","volume":"44","author":"Avramis","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R12-20251107","first-page":"4554","article-title":"L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans","volume":"41","author":"Riccardi","year":"1981","journal-title":"Cancer Res"},{"key":"R13-20251107","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood.V99.6.1986","article-title":"A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study","volume":"99","author":"Avramis","year":"2002","journal-title":"Blood"},{"key":"R14-20251107","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1365-2141.1997.d01-2089.x","article-title":"Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukaemia","volume":"96","author":"Ahlke","year":"1997","journal-title":"Br J Haematol"},{"key":"R15-20251107","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1007\/s00216-018-1326-x","article-title":"A critical analysis of L-asparaginase activity quantification methods-colorimetric methods versus high-performance liquid chromatography","volume":"410","author":"Magri","year":"2018","journal-title":"Anal Bioanal Chem"},{"key":"R16-20251107","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0021-9258(19)42886-X","article-title":"Substrate binding and intersubunit interactions in L-asparaginase","volume":"249","author":"Shifrin","year":"1974","journal-title":"J Biol Chem"},{"key":"R17-20251107","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0043-1354(76)90154-8","article-title":"Determination of ammonia and kjeldahl nitrogen by indophenol method","volume":"10","author":"Scheiner","year":"1976","journal-title":"Water Res"},{"key":"R18-20251107","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/abio.2000.4500","article-title":"A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy","volume":"280","author":"Ylikangas","year":"2000","journal-title":"Anal Biochem"},{"key":"R19-20251107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.161.3836.62","article-title":"5-Diazo-4-oxo-L-norvaline: reactive asparagine analog with biological specificity","volume":"161","author":"Handschumacher","year":"1968","journal-title":"Science"},{"key":"R20-20251107","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0003-2697(02)00232-4","article-title":"Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum","volume":"309","author":"Lanvers","year":"2002","journal-title":"Anal Biochem"},{"key":"R21-20251107","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.pa.10.040170.002225","article-title":"L-asparaginase and L-asparagine metabolism","volume":"10","author":"Cooney","year":"1970","journal-title":"Annu Rev Pharmacol"},{"key":"R22-20251107","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0076-6879(55)02216-7","article-title":"Glutaminase, asparaginase, and \u03b1-keto acid-\u03c9-amidase","volume":"2","author":"Alton","year":"1955","journal-title":"Methods Enzymol"},{"key":"R23-20251107","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0959-8049(96)00131-1","article-title":"Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations","volume":"32A","author":"Boos","year":"1996","journal-title":"Eur J Cancer"},{"key":"R24-20251107","first-page":"929","article-title":"Evaluation of L-asparagine metabolism in animals and man","volume":"30","author":"Cooney","year":"1970","journal-title":"Cancer Res"},{"key":"R25-20251107","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/ac60017a022","article-title":"Determination of nitrogen in biological materials","volume":"20","author":"Miller","year":"1948","journal-title":"Anal Chem"},{"key":"R26-20251107","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1021\/ac60056a029","article-title":"Determination of organic nitrogen. Control of variables in the use of Nessler's reagent","volume":"23","author":"Thompson","year":"1951","journal-title":"Anal Chem"},{"key":"R27-20251107","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/bmc.1096","article-title":"An isocratic fluorescence HPLC assay for the monitoring of L-asparaginase activity and L-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia","volume":"23","author":"Nath","year":"2009","journal-title":"Biomed Chromatogr"},{"key":"R28-20251107","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00216-015-9222-0","article-title":"\u201cReagent-free\u201d L-asparaginase activity assay based on CD spectroscopy and conductometry","volume":"408","author":"Kudryashova","year":"2016","journal-title":"Anal Bioanal Chem"},{"key":"R29-20251107","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/bjc.1968.71","article-title":"Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors","volume":"22","author":"Broome","year":"1968","journal-title":"Br J Cancer"},{"key":"R30-20251107","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0021-9258(19)50936-X","article-title":"The enzymatic formation of hydroxamic acids from glutamine and asparagine","volume":"187","author":"Grossowicz","year":"1950","journal-title":"J Biol Chem"},{"key":"R32-20251107","doi-asserted-by":"crossref","first-page":"134","DOI":"10.12793\/tcp.2018.26.3.134","article-title":"Development of a UPLC-MS\/MS method for the therapeutic monitoring of L-asparaginase","volume":"26","author":"Jeong","year":"2018","journal-title":"Transl Clin Pharmacol"},{"key":"R35-20251107","doi-asserted-by":"crossref","first-page":"4641709","DOI":"10.1155\/2020\/4641709","article-title":"Simultaneous determination of 34 amino acids in tumor tissues from colorectal cancer patients based on the targeted UHPLC-MS\/MS Method","volume":"2020","author":"Yang","year":"2020","journal-title":"J Anal Methods Chem"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:00:41Z","timestamp":1762542041000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001345","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"2024-06-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}